01:11 PM EDT, 07/18/2025 (MT Newswires) -- Health care stocks declined Friday afternoon with the NYSE Health Care Index dropping 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.7%.

The iShares Biotechnology ETF (IBB) fell 1.4%.

In corporate news, Sarepta Therapeutics ( SRPT ) shares tumbled 34%. The company's gene therapy Elevidys is under US Food and Drug Administration review with the agency evaluating whether it should remain on the market, Bloomberg reported, citing FDA Commissioner Marty Makary. Bloomberg reported earlier that another person died from acute liver failure after receiving one of the company's gene therapies.